AssetMark Inc’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-31,277
Closed -$10.2M 2264
2024
Q1
$10.2M Buy
31,277
+7,016
+29% +$1.72M 0.03% 297
2023
Q4
$4.62M Buy
24,261
+2,199
+10% +$416K 0.02% 387
2023
Q3
$4.39M Buy
22,062
+3,769
+21% +$891K 0.02% 362
2023
Q2
$5.22M Buy
18,293
+1,315
+8% +$365K 0.02% 336
2023
Q1
$3.68M Buy
16,978
+14,755
+664% +$2.88M 0.02% 358
2022
Q4
$457K Buy
2,223
+724
+48% +$183K ﹤0.01% 715
2022
Q3
$417K Buy
1,499
+557
+59% +$142K ﹤0.01% 681
2022
Q2
$180K Buy
942
+745
+378% +$132K ﹤0.01% 754
2022
Q1
$41K Buy
+197
New +$32.5K ﹤0.01% 965

Other funds holding SWAV

AssetMark Inc's SWAV Position: Q2 2024 in Review

AssetMark Inc sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 31,277 shares — an estimated $10.2M sold.

AssetMark Inc first reported a position in SWAV in Q1 2022 and held it in 9 quarters. The position peaked at $10.2M in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • AssetMark Inc reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • AssetMark Inc sold 31,277 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $10.2M.
  • AssetMark Inc first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2022 and held it in 9 quarters.
  • AssetMark Inc's Shockwave Medical, Inc. Common Stock position peaked at $10.2M in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on AssetMark Inc's 13F filing for Q2 2024, filed 13 Aug 2024.